Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Genome Medicine2013Vol. 5(4), pp. 30–30
Citations Over TimeTop 10% of 2013 papers
Ellen Heitzer, Peter Ulz, Jelena Belic, Stefan Gutschi, Franz Quehenberger, Katja Fischereder, Theresa Benezeder, Martina Auer, Carina Pischler, Sebastian Mannweiler, Martin Pichler, Florian Eisner, Martin Haeusler, Sabine Riethdorf, Klaus Pantel, Hellmut Samonigg, Gerald Höefler, Herbert Augustin, Jochen B. Geigl, Michael R. Speicher
Abstract
The genomic landscape of prostate cancer can be established by non-invasive means from plasma DNA. Our approach provides specific genomic signatures within 2 days which may therefore serve as 'liquid biopsy'.
Related Papers
- → Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer(2007)116 cited
- → Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells(2010)100 cited
- → Die TMPRSS2-ETS-Genfusion beim Prostatakarzinom(2007)16 cited
- → Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer(2015)9 cited
- Recent Research Progress of TMPRSS2-ERG Gene Fusions in Prostate Cancer(2012)